2^ndInternational Conference on

Tumor & Cancer Immunology and Immunotherapy

July 17-18, 2017

Emerging Technologies and treatment in Tumor & Cancer immunotherapy from vaccines to antibodies and cell therapies

Submit Abstract Register Now Sessions & Tracks Program Schedule Reader Base Awards Nomination Market Analysis

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Nickolai Usachev

PSI Company, Ltd., Russia

Biography

Nickolai Usachev has substantial practical expertise in cardiology and intensive care, combined with more than decade’s experience in the field of clinical studies. Since 2009 Dr.Usachev heads the Pharmacovigilance unit of PSI CRO.

Abstract

Abstract : Is elevated troponin T reliable enough to be the only screen-out factor in pre-treated lymphoma patients?